Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06282510 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nasal Antisepsis for C. Auris Prevention

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Feb 26, 2025, no change to tracked fieldsv2-v3
  2. Study First Submitted
This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.
Trial Details
NCT Number NCT06282510
Lead Sponsor Mary K Hayden
Collaborators: Rush University Medical Center, RML Specialty Hospital
Conditions
(from sponsor)		 Candida Auris Infection, Colonization, Asymptomatic
Related terms Asymptomatic Infections, Candida auris infection
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov